Table 3 Weight and tumor Inhibition rate in different experimental groups of mice (x ± s.d., n = 10).

From: Effects of the mitoxantrone thermosensitive liposome nanodelivery system on prostate cancer in vivo and in vitro

Treatment group

Tumor weight (g)

Inhibition rate (%)

MTX-TSL with prehyperthermia

0.235 ± 0.0263

86.1 **▲▲

MTX-TSL with posthyperthermia

1.098 ± 0.0682

34.8

MTX-L

0.405 ± 0.0321

76.0 **▲▲

MTX-free

1.216 ± 0.0516

27.9

Control

1.686 ± 0.0520

 
  1. *P < 0.05 and **P < 0.01 compared with the control group; ▲P < 0.05 and ▲▲P < 0.01 compared with the MTX-free group.